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Abstract
Background and Aims: Major depression can be treated by means of cognitive behavior therapy, delivered via the Internet
as guided self-help. Individually tailored guided self-help treatments have shown promising results in the treatment of
anxiety disorders. This randomized controlled trial tested the efficacy of an Internet-based individually tailored guided self-
help treatment which specifically targeted depression with comorbid symptoms. The treatment was compared both to
standardized (non-tailored) Internet-based treatment and to an active control group in the form of a monitored online
discussion group. Both guided self-help treatments were based on cognitive behavior therapy and lasted for 10 weeks. The
discussion group consisted of weekly discussion themes related to depression and the treatment of depression.
Methods: A total of 121 participants with diagnosed major depressive disorder and with a range of comorbid symptoms
were randomized to three groups. The tailored treatment consisted of a prescribed set of modules targeting depression as
well as comorbid problems. The standardized treatment was a previously tested guided self-help program for depression.
Results: From pre-treatment to post-treatment, both treatment groups improved on measures of depression, anxiety and
quality of life. The results were maintained at a 6-month follow-up. Subgroup analyses showed that the tailored treatment
was more effective than the standardized treatment among participants with higher levels of depression at baseline and
more comorbidity, both in terms of reduction of depressive symptoms and on recovery rates. In the subgroup with lower
baseline scores of depression, few differences were seen between treatments and the discussion group.
Conclusions: This study shows that tailored Internet-based treatment for depression is effective and that addressing
comorbidity by tailoring may be one way of making guided self-help treatments more effective than standardized
approaches in the treatment of more severe depression.
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Introduction
Major depressive disorder is now considered a world-wide
problem, especially in middle- and high-income countries [1].
Several different psychological treatments exist, which are
considered to be fairly equivalent in terms of efficacy [2].
Computerized cognitive behavior therapy and Internet-delivered
psychological treatments are available for several psychiatric
disorders [3]. Recent meta-analyses have found small to moderate
effects of computerized treatments for depression and anxiety
disorders [4,5].
Research clearly suggests that comorbidity is the rule rather
than the exception when it comes to major depression. For
example, it has been found that comorbid anxiety syndromes such
as social phobia occur frequently, and it has been found that at
least 50% of depressed persons also fulfill the diagnostic criteria of
an anxiety disorder [6].
Related to comorbidity with depression is depression severity. It
is known that increased levels of depression are associated with
higher prevalence of comorbidity of e.g. anxiety disorders and
substance abuse [7]. Depression severity is also known to be a
significant factor in the treatment of depression. For example,
there are some evidence that there is a difference in efficacy
between two forms of cognitive behavioral therapy in the
treatment of the more severely depressed patients [8]. Another
result related to depression severity is that there are indications
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is evident in severe depression, but not in mild to moderate
depression [9]. These results suggest that baseline depression
severity may moderate response even in different variants of
Internet-delivered CBT (ICBT).
Tailoring the treatment to the clients’ need could be one way to
address comorbidity. The procedure of tailoring is encouraged in
various ways in face-to-face CBT [10,11], but is less common in
ICBT. While tailoring has been used in ICBT to some degree, e.g.
for tinnitus [12], depression [13], panic [14] and anxiety disorders
[15], it has to our knowledge never been directly compared to
standardized (non-tailored) ICBT in a randomized controlled trial.
Tailoring in ICBT typically combines modules from different
treatment packages, resulting in different prescriptions for different
patients, depending on primary diagnosis and comorbidity (e.g.
[15]).
Another way of treating disorders with comorbidity is to use
unified treatments, where all patients are provided with the same
protocol but the protocol itself is constructed to fit a broader range
of patients [16]. Recently, there have been evidence of the efficacy
of unified ICBT treatments for depression and anxiety disorders
[17,18].
The aim of this trial was to investigate the effects of an
individually tailored ICBT treatment which directly targeted both
depression and comorbid symptoms. The treatment was based on
treatment modules from previous treatment protocols and were
individually prescribed to the participants. We compared the
tailored treatment both to standardized treatment and to an active
control group in the form of a monitored online discussion group,
which focused on depression. An effect was expected for both CBT
treatments, where a larger effect was expected for the tailored
treatment. While it has been found that online support groups can
have a small effect [19], we expected that this effect would be
smaller than in the treatment conditions. We also included a 6-
month follow-up after completion of the treatment.
Methods
Ethics statement
The study was approved by the Regional Ethics Board of
Linko ¨ping, Sweden. Written informed consent was obtained from
all participants by surface mail.
Recruitment and selection
The participants were recruited from an online waiting list for
people interested in Internet-based treatment for depression.
There was also an advertisement made in a large Swedish
newspaper the week before the study formally started. Those who
were interested were directed to a web page with information
about the study, the treatments being tested and the therapists.
From there it was possible to make an application for participation
in the study.
The selection process started with an online screening. All
participants answered online versions of the Beck Depression
Inventory-II (BDI–II; [20]), the self-rated version of the Mon-
tgomery-A ˚sberg Depression Rating Scale (MADRS-S; [21]), the
Beck Anxiety Inventory (BAI; [22]) and the Quality of Life
Inventory (QOLI; [23]). The outcome measures used have
established good psychometric properties, also when administered
via the Internet [24,25]. The results from the online screening
procedure were later used as pre-treatment assessment for those
included in the study.
To cover comorbidity, a set of diagnostic screening questions
were given. The questions were given online in self-report format
according to a decision tree structure inspired by the PrimeMD
[26]. Areas covered were depression, panic disorder, generalized
anxiety disorder, social phobia, stress and insomnia. There were
also some additional demographic questions and questions on
alcohol consumption.
An algorithm in the screening system marked a participant as
potentially having a diagnosis and/or a specific problem when
answering according to a predefined criteria. To be marked with
potential depression, panic disorder, generalized anxiety disorder
or social phobia the participant had to answer affirmative to a set
of question similar to the diagnostic criteria from the DSM-IV.
The screening for stress and insomnia worked slightly different. If
confirming these problems by answering affirmative to a set of
screening questions, the participants were directed to online
version of the Perceived Stress Scale (PSS; [27]) and the Insomnia
Severity Index (ISI; [28]). To be marked as having problems with
stress or insomnia a participant had to answer above a pre-set
score on these measures. The cutoffs used were 15 for the ISI [28]
and 25 for the PSS [29].
Inclusion criteria for the study were a) being at least 18 years
old, b) having a total of .14 on MADRS-S and c) a total of ,36
on MADRS-S, d) ,5 on MADRS-S item 9 (about suicidal
ideations), e) reported unchanged dosage of medication for
depression and anxiety during the last three months, f) reported
no concurrent psychological treatment, g) not suffering from a
severe psychiatric condition that could interfere with the treatment
(e.g. bipolar disorder or schizophrenia, measured in a clinical
interview), h) not having other primary medical problems which
would need other treatments first hand, i) not having severe
alcohol problems, j) a diagnosis of major depressive disorder
according to the DSM-IV, with a current acute episode of
depression or an episode in partial remission.
The diagnosis of major depressive disorder was confirmed using
the Structured Clinical Interview for DSM-IV–Axis I disorders
(SCID-I; [30]). The interviews were conducted by telephone by
seven MSc clinical psychology students and one medical student.
All interviewers were trained in the diagnostic procedures using
SCID-I. While the interviewers were not blind to the results from
the online screening, the diagnostic interviews were similar for all
participants.
The senior researcher (licensed psychotherapist) reviewed all the
protocols from the interviews together with a psychiatrist and the
interviewers. Issues of medication and psychiatric history that
came up in the interview were considered before inclusion was
made.
Of the 255 individuals who initially expressed interest in the
study, 121 were subsequently included after the SCID-I had been
conducted. The reasons for exclusion are specified in the flowchart
found in Figure 1.
Among the randomized participants there were 71.1% women
(n=86) and 28.9% men (n=35). The mean age was 45 years
(SD=12.1) ranging from 20 to 75 years. Sixty-two percent (n=75)
had an experience of previous psychological treatment or were in a
treatment which was not considered to interfere with the study
(e.g. supportive care). Sixty-nine percent (n=84) were on
medication or had a history of taking medication. See Table 1
for additional demographical data. There were no significant
between-group differences in demographics. Regarding the
outcome measures, there were no significant differences on any
of the measures of depression and anxiety at baseline (all
F’s,0.506, all p’s..60). There was a tendency to pre-treatment
differences on the QOLI, but not significant (F(2,118) =2.60,
n=.079).
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The screening procedure described above provided a measure
of comorbidity. As seen in Table 1, stress and insomnia were most
prevalent (76.0% and 39.7% respectively). A smaller proportion
(29.8%) presented problems of social anxiety, 23.1% had problems
with worry, and 16.5% had symptoms of panic disorder. More
than half of the sample (54.5%) had a potential comorbid anxiety
disorder and a large majority of the participants (91.7%) had any
comorbid problem. The mean number of comorbid problems was
M=1.85 (SD=1.04).
Treatments and therapists
Both CBT treatments were given as guided self-help which
meant that the participants downloaded self-help chapters which
they worked on by themselves with e-mail support from a
therapist. The delivery of the text chapters and the e-mail contact
Figure 1. Participant flow and reasons for dropping out throughout the trial. Abbreviations: MADRS-S: Montgomery-A ˚sberg Depression
Rating Scale–Self-rated version; SCID: Structured Clinical Interview for DSM-IV Axis I Disorders.
doi:10.1371/journal.pone.0036905.g001
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which was secured both by a password and one-time codes which
was sent to the participants by surface mail. All chapters had text
information and exercises. For example, the material on cognitive
restructuring given in both treatments contained information
about the cognitive model of depression and exercises on how to
register and challenge negative automatic thoughts. The partici-
pants had continuous contact with a therapist by e-mail. Most of
the contact was related to feedback on exercises, but the
participants were encouraged to contact the therapist in other
issues (e.g. when not understanding the text material) and was
guaranteed an answer within 24 hours during workdays. The
therapists also sent e-mails to the participants if there had not been
any contact for a week. This version of guided self-help has been
described further elsewhere, e.g. in [3].
The standardizeed treatment consisted of eight self-help
chapters, containing behavioral activation, cognitive restructuring,
sleep management, general health advice and relapse prevention.
The material has previously been tested in two randomized
controlled trials [31,32]. Even though the treatment contained
eight chapters, it lasted for 10 weeks, which meant that the
participant stayed in contact with the therapist for all 10 weeks
and could work with some chapters longer than a week and still
finish in time.
Table 1. Demographic description of the participants at randomization.
Tailored Standardized Control Total
Gender Female 29 (74.4%) 28
a (70%) 29 (69%) 86 (71.1%)
Male 10 (25.6%) 12 (30%) 13
a (31%) 35 (28.9%)
Age Mean (SD) 45.7 (10.9) 43.7 (13.7) 44.8 (11.8) 44.7 (12.1)
Min-Max 22–68 20–70 21–75 20–75
Marital status Married 16 (41%) 18 (45%) 25 (59.5%) 59 (48.8%)
Single 21 (53.8%) 14 (35%) 14 (33.3%) 49 (40.5%)
Other 2 (5.1%) 8 (20%) 3 (7.1%) 13 (10.7%)
Highest educational
level
Nine year compulsory
school
2 (5.1%) 0 1 (2.4%) 3 (2.5%)
Secondary school
(compl.)
6 (15.4%) 14 (35%) 15 (35.7%) 35 (28.9%)
College/university
(not compl.)
7 (17.9%) 9 (22.5%) 3 (7.1%) 19 (15.7%)
College/university
(compl.)
23 (59%) 17 (42.5%) 23 (54.8%) 63 (52.1%)
Other 1 (2.6%) 0 0 1 (0.8%)
Employment status Employed 25 (64.1%) 24 (60%) 31 (73.8%) 80 (66.1%)
Unemployed 4 (10.3%) 4 (10%) 3 (7.1%) 11 (9.1%)
Student 2 (5.1%) 6 (15%) 2 (4.8%) 10 (8.3%)
Retired 5 (12.8%) 5 (12.5%) 2 (4.8%) 12 (9.9%)
Other 3 (7.7%) 0 3 (7.1%) 6 (5.0%)
Medication None 15 (38.5%) 10 (25%) 12 (28.6%) 37 (30.6%)
Earlier 15 (38.5%) 18 (45%) 13 (31%) 46 (38%)
Present 9 (23.1%) 12 (30%) 17 (40.5%) 38 (31.4%)
Psychological
treatment
None 18 (46.2%) 11 (27.5%) 17 (40.5%) 46 (38%)
Earlier 19 (48.7%) 26 (65%) 22 (52.4%) 67 (55.4%)
Present 2 (5.1%) 3 (7.5%) 3 (7.1%) 8 (6.6%)
Depression In acute episode 31 (79.5%) 27 (67.5%) 31 (73.8%) 89 (73.6%)
In partial remission 8 (20.5%) 13 (32.5%) 11 (26.2%) 32 (26.4%)
Dysthymia 6 (15.4%) 4 (10.0%) 7 (16.7%) 17 (14.0%)
Comorbidity Panic 6 (15.4%) 9 (22.5%) 5 (11.9%) 20 (16.5%)
Worry 11 (28.2%) 7 (17.5%) 10 (23.8%) 28 (23.1%)
Social fear 14 (35.9%) 13 (32.5%) 9 (21.4%) 36 (29.8%)
Any anxiety 24 (61.5%) 22 (55.5%) 20 (47.6%) 66 (54.5%)
Stress 32 (82.1%) 28 (70.0%) 32 (76.2%) 92 (76.0%)
Sleep 15 (38.5%) 15 (37.5%) 18 (42.9%) 48 (39.7%)
Any 38 (97.4%) 35 (87.5%) 38 (90.5%) 111 (91.7%)
aTwo participants (one from the standardized treatment group and one from control), described themselves as ‘‘transgender’’ but are reported here according to their
biological gender.
doi:10.1371/journal.pone.0036905.t001
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treatment material on depression, panic, social anxiety, worrying
and additional material e.g. on stress management, concentration
problems, problem solving strategies, mindfulness and relaxation.
All chapters were based on CBT principles. An individualized
treatment plan was prepared for each participant randomized to
the tailored treatment. The treatment plans were formed by
discussion in the research group and were mainly based on the
SCID interview and results from self-report measures. All
treatment plans were made to last for 10 weeks. The average
number of treatment chapters assigned to the participants was 9.7
(SD=0.65), ranging from 8 to 10.
The therapists were seven MSc-level clinical psychologist
students who had received clinical training. During the whole
study the therapists had continuous supervision from an experi-
enced psychotherapist. The participants were randomized to the
therapists. The number of participants that each therapist was
responsible for ranged from 9 to 13.
Active control group
The participants who were randomized to the active control
group were invited to participate in a moderated online discussion
group during the waiting period of 10 weeks. Every week a new
discussion topic was presented by the moderator. The topics were
all in some way related to depression and/or treatment of
depression. The participants were encouraged to use the discussion
group during the treatment period. A few weeks after the
treatment groups had finished their treatment, the control group
received the standardized treatment, with support given when
needed. At follow-up, all participants had received or had been
offered treatment. However, the present analysis only contains
data from the control group up the point before taking part of the
standardized treatment.
Procedure and design
The protocol for this trial and supporting CONSORT checklist
are available as supporting information; see Checklist S1 and
Protocol S1. Participants were allocated using an online random-
ization tool (www.random.org), handled by an independent person
who was separate from the staff conducting the study. All measures
that were collected before the treatment started were also included
at mid-treatment, post-treatment and at 6 months follow-up. At
post-treatment and at follow-up a structured telephone interview
was also conducted. The purpose of the interview was to give an
estimation of global improvement, measured by the 7-point
version of the Clinical Global Impression–Improvement scale
(CGI-I; [33]). The interviewers had no association to the research
project and were blind to which group the participants had been
randomized.
Subgroups based on baseline depression severity
All randomized participants were classified into either higher or
lower severity of depression. These classes were formed based on
median baseline scores on the BDI–II. Participants with an initial
depression score of BDI–II .24 (n=60) were classified as higher
severity and those with BDI–II ,25 (n=61) as lower severity.
There were significant baseline differences on all outcome
measures between the two classes (all t’s.4.68; all p’s,.001).
The mean number of comorbid problems was also higher in the
high severity group (M=2.32 compared to M=1.39; t(119)
=5.44, p,.001). Comorbid anxiety disorders were more prevalent
in the high severity group (all x2’s.6.19; all p’s,0.05). Insomnia
and stress problems had a tendency to be more prevalent among
participants with higher initial severity, but did not reach statistical
significance (p=.053 and p=.15 respectively).
Data analysis
Group differences in demographic data, pre-treatment mea-
sures and in clinical significant improvement were tested using chi-
square tests and one-way analysis of variance. Data from the three
groups were collected before treatment, five weeks into the
treatment, after treatment and at 6-month follow-up. The data
was analyzed using mixed effects models, given their ability to
handle missing data [34]. Analyses comparing all three groups
used the pre-, mid- and post-treatment data while analyses
comparing the two ICBT treatments also included the follow-up
data. Between-group differences at post-treatment and at follow-
up were analyzed using independent t-tests. Analyses concerning
the subgroups with higher and lower pre-treatment depression
severity were done separately. All analyses were performed in
SPSS version 19.0 (SPSS, Inc., Chicago, IL). Six participants were
excluded from the analyses since they did not start treatment. In
addition, one participant from the tailored treatment group scored
close to maximum on all measures at follow-up, resulting in a total
score more than three standard deviations from the rest of the
participants. The participant was therefore marked as an outlier
and the follow-up scores were marked as missing.
Recovery after treatment was investigated using the BDI–II. On
the BDI–II, recovery was defined as a post-treatment score #10.
This definition is in line with previous clinical trials on depression
(e.g. [8,35]). The participants who did not provide post-treatment
data were classified as non-recoverers. Within- and between-group
effect sizes were calculated by dividing the differences in means by
the pooled standard deviations [36].
Results
Results from the mixed-effects model analyses are presented
below. In all analyses, random intercept models were used and a
Maximum Likelihood method and a covariance type based on the
variance components were employed to provide the estimates.
Means, standard deviations and effect sizes within and between
groups for all self-report measures are presented in Table 2. The
between-group effect sizes (Cohen’s d) can be interpreted as
follows: an effect size in the range of 0.20–0.49 is small, while
0.50–0.79 is moderate, and an effect size over 0.80 is large [37].
Measures of depression
Mixed-effects model analyses on the BDI–II and the MADRS-S
revealed significant interaction effects of group and time,
indicating a difference between groups from pre-treatment to post
(F(2, 317.6) =11.7 and F(2, 325.4) =11.9 for the BDI–II and the
MADRS-S respectively, both p’s,.001). At post-treatment there
were, as seen in Table 2, large effect sizes between tailored
treatment and control (post-hoc t’s.3.46 and p’s,.001) and
moderately large effect sizes between standardized treatment and
control (post-hoc t’s.2.41 and p’s,.05). Within-group effect sizes
were at post-treatment and at follow-up around d=1.5 for the
tailored treatment and d=1.0 for the standardized treatment.
The effect sizes between ICBT groups at post and at follow-up
were in the range 0.19 to 0.27 and mixed-effects model analyses
failed to reveal significant interaction effects of group and time.
There was however, a close to significant interaction effect of
group and time on the BDI–II (F(1,274.5) =3.48, p=.063) from
pre-treatment to follow-up.
Larger differences between ICBT groups were seen in the
subgroup with higher initial depression severity. Mixed-effects
Tailored vs. Standardized ICBT for Depression
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time on the BDI–II (F(1, 102.4) =6.19, p,.05) and on the
MADRS-S (F(1, 101.2) =5.00, p,.05) from pre-treatment to post-
treatment, favoring the tailored treatment compared to the
standardized approach. This is mirrored by between-group effect
sizes of d =0.69 and d=0.82 on the BDI–II and the MADRS-S
respectively, as seen in Table 2.
On the contrary, when investigating the lower severity group,
no interaction effects of group and time was found between the
three groups from pre-treatment to post-treatment or between the
ICBT groups from pre-treatment to follow-up. This indicates that
Table 2. Means, SDs and effect sizes (Cohen’s d) for measures of depression, anxiety and quality of life.
Pre Post Effect sizes Post Follow-up Effect sizes FU
Measure Group n Mean (SD) n Mean (SD)
Pre to
Post
TA
vs ST
TA/ST vs
CO n Mean (SD)
Pre to
FU
TA vs
ST
Total
BDI–II TA 36 26.44 (7.6) 36 13.78 (9.4) 1.48 0.23 0.84 35 13.00 (9.7) 1.55 0.27
ST 37 25.30 (8.0) 34 16.06 (10.4) 0.98 0.57 34 15.71 (10.4) 1.01
CO 42 26.24 (7.9) 39 21.67 (9.5) 0.51
MADRS-S TA 36 22.86 (3.9) 36 13.81 (6.8) 1.54 0.19 0.80 35 12.80 (7.6) 1.57 0.21
ST 37 22.46 (5.7) 34 15.21 (7.7) 1.06 0.58 34 14.44 (8.3) 1.08
CO 42 23.40 (4.7) 39 19.67 (7.8) 0.55
BAI TA 36 14.08 (5.7) 36 9.69 (5.8) 0.76 0.39 0.69 35 8.74 (6.3) 0.90 0.36
ST 37 16.59 (9.2) 34 12.41 (7.9) 0.53 0.28 34 11.38 (8.3) 0.63
CO 42 15.74 (8.1) 39 14.69 (8.4) 0.05
QOLI TA 36 20.77 (1.3) 36 0.69 (1.8) 0.90 0.05 0.25 35 0.82 (1.9) 0.89 0.05
ST 37 20.28 (1.7) 34 0.79 (1.8) 0.59 0.30 34 0.72 (1.9) 0.54
CO 42 20.15 (1.5) 39 0.24 (1.8) 0.22
High level of depression
BDI–II TA 18 32.78 (4.6) 18 14.11 (10.7) 2.19 0.51 1.29 18 15.56 (11.2) 1.76 0.69
ST 17 32.12 (6.6) 16 19.25 (9.4) 1.57 0.82 16 22.69 (9.2) 1.21
CO 23 31.74 (6.2) 21 26.81 (9.0) 0.65
MADRS-S TA 18 24.33 (3.6) 18 13.17 (5.7) 2.21 0.56 1.54 18 14.00 (8.2) 1.37 0.82
ST 17 26.29 (4.9) 16 16.94 (7.8) 1.51 0.83 16 20.31 (7.1) 1.12
CO 23 25.70 (4.7) 21 23.00 (6.9) 0.43
BAI TA 18 17.67 (5.2) 18 10.33 (5.5) 1.37 0.47 1.47 18 9.11 (5.3) 1.63 0.82
ST 17 20.06 (9.7) 16 13.56 (8.1) 0.70 0.81 16 14.62 (8.1) 0.58
CO 23 19.70 (7.5) 21 19.52 (6.8) 20.07
QOLI TA 18 21.07 (1.2) 18 0.97 (1.9) 1.24 0.37 1.02 18 0.66 (2.0) 1.00 0.45
ST 17 21.10 (1.4) 16 0.28 (1.9) 0.84 0.63 16 0.18 (1.7) 0.61
CO 23 20.97 (1.3) 21 20.77 (1.5) 0.14
Low level of depression
BDI–II TA 18 20.11 (3.6) 18 13.44 (8.2) 1.01 20.02 0.31 17 10.29 (7.1) 1.62 20.11
ST 20 19.50 (2.9) 18 13.22 (10.7) 0.64 0.28 18 9.50 (7.1) 1.73
CO 19 19.58 (3.2) 18 15.67 (5.9) 0.78
MADRS-S TA 18 21.39 (3.6) 18 14.44 (7.9) 0.98 20.10 0.18 17 11.53 (7.0) 1.74 20.38
ST 20 19.20 (4.1) 18 13.67 (7.5) 0.82 0.29 18 9.22 (5.2) 2.07
CO 19 20.63 (3.0) 18 15.78 (7.0) 0.88
BAI TA 18 10.50 (3.6) 18 9.06 (6.2) 0.27 0.33 0.00 17 8.35 (7.4) 0.30 0.02
ST 20 13.65 (7.8) 18 11.39 (7.9) 0.37 20.33 18 8.50 (7.5) 0.75
CO 19 10.95 (5.9) 18 9.06 (6.3) 0.24
QOLI TA 18 20.47 (1.2) 18 0.41 (1.8) 0.54 0.48 0.63 17 0.98 (2.0) 0.77 20.30
ST 20 0.42 (1.7) 18 1.24 (1.7) 0.43 0.11 18 1.51 (1.6) 0.60
CO 19 0.83 (1.2) 18 1.42 (1.4) 0.44
Abbreviations: TA: Tailored ICBT; ST: Standardized ICBT; CO: Control group; Pre: Pre-treatment, Post: Post-treatment; FU: 6 month follow-up; BDI–II: Beck Depression
Inventory-II; MADRS-S: Montgomery-A ˚sberg Depression Rating Scale – Self-rated version; BAI: Beck Anxiety Inventory; QOLI: Quality of Life Inventory.
doi:10.1371/journal.pone.0036905.t002
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treatments for the less severely depressed participants.
Measures of anxiety and quality of life
The results from the BAI and the QOLI are shown in Table 2.
Mixed effects model analyses showed significant interaction effect
of group and time on both measures from pre-treatment to post-
treatment (F(2, 285.5) =6.93 and F(2, 284.5) =5.59 for the BAI
and the QOLI respectively, both p’s,.01). No significant
interaction effect of group and time could be observed on these
measures when comparing the two ICBT treatments, neither in
the total sample nor in the subgroup with higher baseline
depression scores. Similar to the above results for measures of
depression, no interaction effects of group and time were found
between the three groups from pre-treatment to post among the
less severely depressed participants.
Recovery rates and clinical global impression
As seen in Table 3, there were 16 out of 36 (44.4%) from the
tailored treatment who had recovered from depression at post-
treatment. In the standardized treatment and in the control group
the proportion of recoverers were 26.5% (11 out of 37) and 7.7%
(4 out of 42), respectively. At post-treatment, there was a
significant difference between the groups (x
2(2, N=115) =
12.22; p,0.01). Comparing the ICBT groups at post did not
reveal a significant difference in recovery. However, among
participants with higher baseline scores on depression, there were
9 out of 18 (50.0%) from the tailored treatment who had recovered
at post, compared to only 3 out of 17 (17.6%) from the
standardized treatment, resulting in a significant difference x
2(1,
N=35) =4.06; p,0.01. At follow-up the differences were no
longer significant. Among the less severely depressed participants,
no significant differences between groups were found in terms of
recovery.
Of the 115 participants who were analyzed, 102 were reached
for a post-treatment interview and CGI-I measure. At follow-up
104 participants were reached. The proportions of participants
who were considered much or very much improved are shown in
Table 3.
Adherence and therapist time
Adherence to the treatment was measured by the amount of
finished modules per those prescribed. A module was considered
to be finished only if the exercises of the module were completed.
The average percentage finished was 77.2% in the tailored group
and 80.7% in the standardized group t(71) =0.54; p=.59. As
expected, since most participants from the tailored treatment
received more modules, the average therapist time per participant
was larger in the tailored group (95.2 minutes) compared to the
standardized group (74.1 minutes). This difference was significant
t(71) =2.74; p,.05. When comparing the number of minutes per
prescribed module, the difference between tailored (9.7 minutes/
module) and standardized treatment (9.3 minutes/module) was no
longer significant t(71) =0.52; p=.60.
Discussion
The overall aim of this study was to investigate if tailored ICBT
is beneficial for a heterogeneous group of people with major
depressive disorder, where comorbid symptoms were highly
prevalent. The main finding is that the participants who received
tailored and standardized ICBT improved more than the
participants who were part of a moderated online discussion
group with a focus on depression. Despite trends indicating an
advantage of tailored ICBT compared to standardized ICBT, no
significant differences between treatments were found.
This study also explored how different levels of initial depression
severity could moderate response to different treatments. High
baseline depression severity was associated with more comorbidity,
e.g. more anxiety and worse quality of life. For participants with
higher severity, tailored treatment worked better than both the
standardized treatment and the online discussion group, both in
terms of reduction of depressive symptoms and recovery from
depression. In contrast, for participants with lower initial severity,
there were no differences in efficacy between the moderated online
discussion group and the ICBT treatments.
These results call for an explanation of the active mechanisms in
different forms of guided self-help treatment for depression. The
exact workings of the different variants of guided self-help are
largely unknown, but it seems plausible that the tailored treatment
provides a larger set of possible mechanisms. For example,
scheduled worry time is a standard component of CBT for
generalized anxiety disorder, but is not included in standardized
CBT protocols for depression. Hence a patient with a diagnosis of
depression and GAD is likely to benefit more from a tailored
treatment, which in this case could possibly operate both by e.g.
challenging negative core beliefs and by scheduling worrying. The
absence of difference in efficacy between conditions for patients of
lower severity, could mean that specific mechanisms beyond e.g.
expectancy are not active when treating low-severity patients. If
this indeed is the case, it would be in line with recent studies on the
treatment mechanisms beyond placebo in antidepressants [9].
There are limitations of the study that need to be mentioned.
One of the most obvious limitations is that the study was
underpowered to detect significant overall differences between the
two ICBT treatments, even if trends of between-group effects were
found on the BDI–II. A post-hoc power analysis of post-treatment
data on the BDI–II between the ICBT treatments revealed that,
assuming an a-level of .05, one would need a between-group effect
size of d=0.69 to achieve 80% power.
Another limitation is the choice of outcome measures. Even if
all outcome measures are established measures of depression,
anxiety and quality of life, the BAI has been criticized for
measuring primarily symptoms of panic [38]. Thus, BAI does
probably not capture all comorbidity in the sample. Finding a
balance between a few global or many specific measures is a
challenge for future research on tailored and unified treatments
targeting more than one specific disorder.
A related limitation is the measure of comorbidity. In the
present study, a set of online screening questions with a decision
tree structure were used to detect comorbid problems. While
preserving the structure from the PrimeMD, it is still unknown if
this data is a valid measure of comorbidity. Future research should
investigate the validity of such a screening system and how
accurate it can be in the process of identifying psychiatric
diagnoses.
A further limitation concerns the therapists in the study who all
were psychologists in training, albeit during the last semester of
training in a five year program. There is some evidence that
students are less effective as therapists when conducting face-to-
face therapy [39]. Therefore, it is possible that experienced
therapists would have performed even better. This hypothesis can
be contrasted with recent indications that a computer technician
can conduct ICBT as good as a clinician [40,41]. These recent
results call for further research on who can conduct ICBT.
Some clinical implications of this study are discussed as follows.
Since comorbidity is so common with major depression, one
important implication is that tailoring may be a way of addressing
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for more depressed patients. While tailoring may add a small
treatment effect, it is still reasonable that standardized treatments
or maybe even online discussion groups are the best options to use
when the client’s problems are captured by a single diagnosis or
when the problems are subclinical. Future research should
investigate under which conditions tailored treatment is preferable
to standardized treatment.
From a cost-effectiveness perspective, there are probably
differences among the treatments tested in this trial. Tailoring,
as it is conducted in this study, involves prescribing a set of
modules after a thorough assessment. This procedure naturally
takes more time from the clinician than just assigning a fixed
treatment package which is independent of symptom profile.
However, this procedure may be automatized and there are also
indications that patients can prescribe a similarly effective
treatment as a clinician [42]. Further, from a cost-effectiveness
perspective, the results from this study indicate that tailored
treatment with a focus on comorbidity may be a way to reach out
to patients with more severe forms of depression. Depression with
higher severity is associated with even more disability for the
patient and also larger costs for society [43]. Future ICBT research
should focus on conducting larger trials on treatments for this
group of patients.
Insummary,thisstudyisoneofthefirsttotestatailoredapproach
to ICBT for depression and the first to test it directly compared to a
standardized treatment package. The tailored treatment in the
present study targeted comorbidity, which is commonly associated
with major depression. Results from the study indicate that ICBT
thataddressescomorbiditybytailoringmaybemoreeffectivethana
standardized approach for patients with higher depression severity
at baseline. Future studies should focus on when to choose tailored
treatment instead of standardized treatment and on dissemination
issues,forexamplehowtailoredICBTworksinreallifesettings,e.g.
in psychiatry and primary care.
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